About Index Trending news
Analyze
Pricing
Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals is developing novel, broadspectrum antifungal agents for the treatment of lifethreatening invasive fungal infections due to candida, aspergillus and rare molds..

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series C)
$67,000,000
Venture capital (Series B)
$8,700,000
3×5 Partners
Employees

Team size

2
Locations
HQ
$8,700,000 Venture capital (Series B)
FinSMEs

Amplyx Pharmaceuticals Raises $8.7M Investment from 3×5 Partners

Health Funding